← Browse by Condition
Medical Condition
b acute lymphoblastic leukemia
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT05281809 Phase 2
Recruiting
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
Enrollment
30 pts
Location
United States
Sponsor
John Lister
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Enrollment
153 pts
Location
United States, Puert...
Sponsor
National Cancer Institute (NCI...